- Home
- ALPS vs SERA Comparison
ALPS vs SERA Comparison
Compare ALPS & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALPS | SERA |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | Malaysia | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.6M | 75.2M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALPS | SERA |
|---|---|---|
| Price | $0.32 | $2.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | ★ 31.0K | 16.4K |
| Earning Date | 07-24-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $81,000.00 |
| Revenue This Year | N/A | $177.78 |
| Revenue Next Year | N/A | $755.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $0.23 | $1.56 |
| 52 Week High | $1.72 | $3.85 |
Technical Indicators
Market Signals| Indicator | ALPS | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 28.57 | 43.21 |
| Support Level | $0.23 | $1.91 |
| Resistance Level | $0.42 | $2.03 |
| Average True Range (ATR) | 0.01 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 10.90 | 15.38 |
Price Performance
Historical ComparisonAbout ALPS ALPS Group Inc Ordinary Share
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.